Announcement time of this financial report: 2023-10-27 18:40:56
Sichuang Healthcare Technology Co., Ltd. (stock code: 300078) is an enterprise focusing on the field of smart healthcare. It is committed to solving the problems of insufficient medical resources and unbalanced healthcare demand, and promoting the digital transformation of the medical industry. The company uses advanced technologies such as microservices, the Internet of Things, cloud computing, artificial intelligence and big data to promote the application of smart medical equipment and sensors, achieve the acquisition and analysis of medical data, and provide accurate and personalized healthcare services.
In terms of assets and liabilities, Sichuang Healthcare's total assets for the third quarter of 2023 were 3.375 billion yuan, down from 3,649 billion yuan at the end of the previous year. Total liabilities were $2.152 billion, down from $2,317 million at the end of the previous year. Net assets were $1,222 million, down from $1,331 million at the end of the previous year. The balance ratio was 63.78%, up slightly from 63.52% at the end of the previous year.
In terms of profit, the company's operating income for the third quarter of 2023 was 801 million yuan, down from 1,009 million yuan in the same period last year. Operating profit was -104 million yuan. Compared with 1,027,200 yuan in the same period last year, the company lost money in the current period. Net profit was -112 million yuan, compared with $2.2674 million in the same period last year. The company also lost money in the current period. Gross margin was 35.45%, down from 36.69% in the same period last year. The net interest rate was -14.02%, compared to 0.22% in the same period last year. The company also lost money in the current period.
In terms of cash flow, the company's cash inflow from operating activities in the third quarter of 2023 was a subtotal of 979 million yuan, down from 1.05 billion yuan in the same period last year. The total cash outflow from operating activities was $989 million, down from $1,276 million in the same period last year.
In summary, Sichuang Medical's operating conditions in the third quarter of 2023 showed a certain decline compared to the same period last year, and both operating income and net profit declined. However, the company's layout and development potential in the field of smart healthcare are still worth looking forward to. The company responds positively to national policies, promotes digital medical reform, and is committed to building a data-driven smart medical ecosystem, promoting the transformation and upgrading of the medical industry, and contributing to improving the allocation of medical resources and improving the quality of medical services.
For investors, although the company's business conditions declined to a certain extent in the third quarter of 2023, the potential for further cultivation and development in the field of smart healthcare is still worth paying attention to. Investors should comprehensively consider various factors such as the company's business conditions, industry trends, and the company's development strategy when making investment decisions.
This article only represents the judgments made by analysts themselves or analysts based on AI analysis. It cannot be used as an investment indicator, nor does it constitute any investment advice. The original purpose of this article was to help investors analyze and judge capital market data in the most intuitive and fastest way and from the most professional perspective.